US Stock MarketDetailed Quotes

IMUX Immunic

Watchlist
  • 1.515
  • +0.025+1.68%
Trading Sep 13 10:22 ET
136.47MMarket Cap-1010P/E (TTM)

About Immunic Company

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.

Company Profile

SymbolIMUX
Company NameImmunic
Listing DateApr 17, 2014
Issue Price12.00
Founded2003
CEODr. Daniel Vitt, PhD
MarketNASDAQ
Employees77
Fiscal Year Ends12-31
Address1200 Avenue of the Americas,Suite 200
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-332-255-9818
Websitehttp://imux.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Daniel Vitt, PhD
  • Director and Chief Executive Officer
  • 2.56M
  • Jason Tardio, M.B.A.
  • Chief Operating Officer and President
  • --
  • Dr. Hella Kohlhof
  • Chief Scientific Officer
  • --
  • Werner Gladdines
  • Chief Development Officer
  • --
  • Dr. Andreas Muehler
  • Chief Medical Officer
  • 1.46M
  • Patrick Walsh
  • Chief Business Officer
  • --
  • Glenn Whaley
  • Chief Financial Officer
  • 1.48M
  • Dr. Duane D. Nash, M.D.
  • Executive Chairman of the Board
  • 1.07M
  • Simona Skerjanec, M.B.A.
  • Director
  • --
  • Tamar D. Howson
  • Independent Director
  • 76.12K
  • Monika Maria Tornsen
  • Independent Director
  • 125.87K
  • Dr. Jorg Neermann, PhD
  • Independent Director
  • 78.62K
  • Richard Alan Rudick
  • Independent Director
  • --
  • Barclay A. Phillips
  • Lead Independent Director
  • 86.12K
  • Inderpal Singh
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data